No abstract available
Publication types
-
Case Reports
-
Comment
-
Letter
MeSH terms
-
Adolescent
-
Adrenergic Agonists / administration & dosage*
-
Anaphylaxis / drug therapy*
-
Anaphylaxis / etiology
-
Anaphylaxis / immunology
-
Anaphylaxis / pathology
-
Anti-Allergic Agents / administration & dosage
-
Anti-Allergic Agents / adverse effects
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal, Humanized
-
Cetirizine / administration & dosage
-
Cetirizine / adverse effects
-
Epinephrine / administration & dosage*
-
Female
-
Histamine H2 Antagonists / administration & dosage
-
Histamine H2 Antagonists / adverse effects
-
Humans
-
Male
-
Mastocytosis, Systemic / drug therapy
-
Mastocytosis, Systemic / immunology
-
Mastocytosis, Systemic / pathology
-
Middle Aged
-
Omalizumab
-
Ranitidine / administration & dosage
-
Ranitidine / adverse effects
-
Urticaria Pigmentosa / drug therapy
-
Urticaria Pigmentosa / immunology
-
Urticaria Pigmentosa / pathology
Substances
-
Adrenergic Agonists
-
Anti-Allergic Agents
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Histamine H2 Antagonists
-
Omalizumab
-
Ranitidine
-
Epinephrine
-
Cetirizine